The more data becomes available about SARS-CoV-2, the more obvious it becomes that the response to this pandemic has been grossly overblown. Fatality statistics1,2,3,4,5,6,7 from multiple sources, calculated in a variety of ways, show the risk of dying from COVID-19 is lower than your risk of dying from conventional influenza, at least if you’re under the age of 60.
Overall, the data8,9 also
show that the overall all-cause mortality has remained steady this year and
doesn’t veer from the norm. In other words, COVID-19 has not killed off more of
the population than would have died in any given year anyway.
Several studies also suggest immunity against SARS-CoV-2 infection
is far more widespread than anyone imagined, and that the threshold for herd
immunity is far lower than previously estimated.
Most Are Already Immune to
SARS-CoV-2 Infection
Studies supporting the
claim that widespread immunity against SARS-CoV-2 already exists include:
Buy New $25.00(as of 06:10 EST - Details)
•Cell, June 202010,11 — This study found 70% of samples from patients
who had recovered from mild cases of COVID-19 had resistance to SARS-CoV-2 on
the T-cell level. Importantly, 40% to 60% of people who had not been exposed to
SARS-CoV-2 also had resistance to the virus on the T-cell level.
According to the authors,
this suggests there’s “cross-reactive T cell recognition between circulating
‘common cold’ coronaviruses and SARS-CoV-2.” In other words, if you’ve
recovered from a common cold caused by a particular coronavirus, your humoral
immune system may activate when you encounter SARS-CoV-2, thus rendering you
resistant to COVID-19.
•Nature Immunology,
September 202012 — This German study was
initially posted on a preprint server in June 2020 under the title, “SARS-CoV-2
T-cell Epitopes Define Heterologous and COVID-19-Induced T-Cell Recognition.”13
It’s now published in
the September 2020 issue of Nature Immunology with the slightly altered title,
“SARS-CoV-2-Derived Peptides Define Heterologous and COVID-19-Induced T Cell
Recognition.”14 Much like the Cell study above, this investigation
also found that that:
“Cross-reactive SARS-CoV-2 peptides revealed pre-existing T cell
responses in 81% of unexposed individuals and validated similarity with common
cold coronaviruses, providing a functional basis for heterologous immunity in
SARS-CoV-2 infection.”
In other words, even among those who were unexposed, 81% were
resistant or immune to SARS-CoV-2 infection. The term “heterologous immunity”
refers to immunity that develops against a given pathogen after you’ve been
exposed to a nonidentical pathogen.
Typically, this occurs
when viruses are sufficiently similar or from closely related species. In this
case, SARS-CoV-2 appears to be sufficiently similar to coronaviruses that cause
the common cold, so that if you’ve been exposed to any of those coronaviruses,
your immune system is also able to combat SARS-CoV-2.
Buy New $104.53 ($6.58 /
Ounce)(as
of 03:48 EDT - Details)
•The Lancet Microbe,
September 202015,16 — This study found that
rhinovirus infection, responsible for the common cold, largely prevented
concurrent influenza infection by triggering the production of natural
antiviral interferon.
The researchers
speculate that the common cold virus could potentially help protect against
SARS-CoV-2 infection as well. Interferon is part of your early immune response,
and its protective effects last for at least five days, according to the
researchers. Co-author Dr. Ellen Foxman told UPI:17
“Infection with the common cold
virus protected cells from infection with a more dangerous virus, the influenza
virus, and [this] occurred because the common cold activated the body’s general
antiviral defenses.
This may explain why the flu
season, in winter, generally occurs after the common cold season, in autumn,
and why very few people have both viruses at the same time. Our results show
that interactions between viruses can be an important driving force dictating
how and when viruses spread through a population.
Since every virus is different,
we still do not know how the common cold season will impact the spread of
COVID-19, but we now know we should be looking out for these interactions.”
•Nature, July 202018,19,20 — Originally posted on a preprint server in May
2020,21 this Singaporean study was published in the July
2020 issue of Nature.22 Here, they found that common
colds caused by the betacoronaviruses OC43 and HKU1 might make you more
resistant to SARS-CoV-2 infection, and that the resulting immunity could
potentially be long-lasting.
Patients who recovered from SARS infection back in 2003 still
had T cell reactivity to the N protein of SARS-CoV now, 17 years later. These
patients also had strong cross-reactivity to the N protein of SARS-CoV-2.
The authors suggest that
if you’ve beaten a common cold caused by a OC43 or HKU1 betacoronavirus in the
past, you may have a 50/50 chance of having defensive T-cells that can
recognize and help defend against SARS-CoV-2. According to the authors:
Best Price: nullBuy
New $24.95 ($0.28 / Count)(as of 11:05 EST - Details)
“These findings demonstrate
that virus-specific T cells induced by infection with betacoronaviruses are
long-lasting, supporting the notion that patients with COVID-19 will develop
long-term T cell immunity.
Our findings also raise the
possibility that long-lasting T cells generated after infection with related
viruses may be able to protect against, or modify the pathology caused by,
infection with SARS-CoV-2.”
•Cell August 202023,24 — This Swedish study, initially posted on a
preprint server in June 202025 and now
published in the October 2020 issue of the journal Cell,26 found
that SARS-CoV-2-specific memory T cells likely provide long-term immune
protection against COVID-19. According to the authors:27
“Acute-phase
SARS-CoV-2-specific T cells displayed a highly activated cytotoxic phenotype
that correlated with various clinical markers of disease severity, whereas
convalescent-phase SARS-CoV-2-specific T cells were polyfunctional and
displayed a stem-like memory phenotype.
Importantly,
SARS-CoV-2-specific T cells were detectable in antibody-seronegative exposed
family members and convalescent individuals with a history of asymptomatic and
mild COVID-19.
Our collective dataset shows
that SARS-CoV-2 elicits broadly directed and functionally replete memory T cell
responses, suggesting that natural exposure or infection may prevent recurrent
episodes of severe COVID-19.”
Innate and Adaptive Immunity
It’s important to
realize you have two types of immunity. Your innate immune system is primed and
ready to attack foreign invaders at any moment and is your first line of
defense. Your adaptive immune system,28 on the other
hand, “remembers” previous exposure to a pathogen and mounts a response when an
old foe is recognized.
Your adaptive immune
system is further divided into two arms: humoral immunity (B cells) and cell
mediated immunity (T cells). The B cells and T cells are manufactured as needed
from specialized stem cells. The graphs below are from my vitamin D
report and will help you understand the components of these
systems and their timing.
(Link to site below)
If you have never been exposed to a disease but are given
antibodies from someone who got sick and recovered, you can gain humoral
immunity against that disease. Your humoral immune system can also kick in if
there’s cross-reactivity with another very similar pathogen.
As you can see from
the list above, in the case of COVID-19, evidence29 suggests
exposure to other coronaviruses that cause the common cold can confer immunity
against SARS-CoV-2.
On the flip side, there’s a phenomenon known as viral
interference, where exposure to one virus makes you more susceptible to another
virus. Importantly, research30 has found that
those who received the influenza vaccine were 36% more susceptible to
coronavirus infection.
Mathematical Models Add Support
for Widespread Immunity
If it’s true that a
majority already have some measure of immunity against COVID-19 due to previous
exposure to other coronaviruses, then we’ve probably already reached the
threshold for herd immunity, and vaccinating every human on the planet (or
close to it) will not be necessary.
Buy New $39.95 ($7.55 /
Ounce)(as
of 04:42 EDT - Details)
Added support for the
idea that herd immunity may already have been achieved in most countries comes
from statisticians working with mathematical models. In June 2020, Freddie
Sayers, executive editor of UnHerd, interviewed31 professor Karl
Friston, a statistician who claims immunity against SARS-CoV-2, globally, might
be as high as 80%, as reviewed in the video interview above.
Friston is credited with inventing a statistical parametric
mapping technique that is now the standard for understanding brain imaging. As
the pandemic erupted, he began applying this method of analysis (which he
refers to as “dynamic causal modeling”) to COVID-19 data, coming up with a
model that predicts far lower mortality rates than earlier models.
The reason for this is because the “effective susceptible
population,” meaning those who are not already immune to COVID-19 and therefore
at risk of infection, was never 100%. At most, it was 50% and most likely only
around 20%.
Friston’s model effectively
vaporizes claims that social distancing is necessary, because once sensible
behaviors such as staying home when sick are entered into it, the positive
effect of lockdown efforts on “flattening the curve” simply vanish. In all
likelihood, the global lockdowns were completely unnecessary, and certainly
should not continue, now or in the future.
Signs of Herd Immunity Emerge
in Sweden
One country that
bucked the global lockdown trend was Sweden, and they now appear to be head and
neck ahead of most other countries in terms of herd immunity, while having a
death toll that is very similar to nations that destroyed their economy and
sacrificed the population’s mental health in the name of infection control.
Anders Tegnell, the
chief epidemiologist in charge of Sweden’s coronavirus response, has stated32 he does not believe Sweden will see a second wave
with widespread contagion as the country is seeing a rapid decline in positive
tests, indicating herd immunity has been achieved.33
He told The Guardian34 that the primary goal was always merely to slow the
spread to avoid overwhelming medical services. The intention was never to
prevent infection from spreading altogether, which has indeed proven impossible.
This was in fact the
original plan just about everywhere. But while Sweden stuck to the original
goal, and by mid-September boasted all-time low infection rates,35 other nations have twisted response plans to
prevent infection transmission altogether, even among those for whom the risk
of such an infection is vanishingly minor, such as school-aged children.
The two graphs from
The Guardian,36 below, show Sweden’s infection rate and deaths per
million, compared to other countries that enforced stricter lockdown rules.
Herd Immunity Threshold Likely
Below 50%
As reported in “Herd Immunity ‘Ahead of Schedule’” experts
initially estimated that 70% of the population or more would need to be immune
before herd immunity would be achieved. Now, more than a dozen scientists claim
the herd immunity threshold is likely below 50%.
Buy New $19.97 ($0.06 /
Count)(as
of 11:23 EDT - Details)
As stated earlier, if this is true — and as you can see by the
studies reviewed, it appears a majority do have some level of immunity — then
the need for a vaccine more or less vanishes.
Herd immunity is
calculated using reproductive number, or R-naught (R0), which is the estimated
number of new infections that may occur from one infected person.37 R0 of below 1 (with R1 meaning that one person
who’s infected is expected to infect one other person) indicates that cases are
declining while R0 above 1 suggests cases are on the rise.
It’s far from an exact science, however, as a person’s
susceptibility to infection varies depending on many factors, including their
health, age and contacts within a community. The initial R0 calculations for
COVID-19’s herd immunity threshold were based on assumptions that everyone has
the same susceptibility and would be mixing randomly with others in the
community.
“That doesn’t happen
in real life,” Dr. Saad Omer, director of the Yale Institute for Global Health,
told The New York Times.38 “Herd immunity could vary from
group to group, and subpopulation to subpopulation,” or even zip code. When
real-world scenarios are factored into the equation, the herd immunity
threshold drops significantly, with some experts saying it could be as low as
10% to 20%.
The most compassionate approach that balances the risks
and benefits of reaching herd immunity, is to allow those who are at minimal
risk of death to live their lives normally to build up immunity to coronavirus
through natural infection, while better protecting those who are at highest
risk. ~ Great Barrington Declaration
Researchers from
Oxford, Virginia Tech and the Liverpool School of Tropical Medicine are among
those that found39,40 when individual variations in
susceptibility and exposure are taken into account, the herd immunity threshold
dips below 10%.
Independent news
source Off-Guardian also cited41 data from
Stockholm County, Sweden, which shows a herd immunity threshold of 17%,42 as well as an essay by Brown University professor
Dr. Andrew Bostom, who noted:43
“Lead investigator Dr. Gomes,
from the Liverpool School of Tropical Medicine, and her colleagues
concluded: “naturally acquired immunity to SARS-CoV-2 may place populations
over the herd immunity threshold once as few as 10-20% of its individuals are
immune.“44
Separate HIT [herd immunity
threshold] calculations of 9%,45 10-20%,46 17%,47 and 43%48,49 —
each substantially below the dogmatically asserted value of ~70%50 — have
been reported by investigators from Tel-Aviv University, Oxford University,
University College of London, and Stockholm University, respectively.”
Declaration Urges Implementation of Herd Immunity Approach
All in all, there are many reasons to suspect that
continued lockdowns, social distancing and mask mandates are completely unnecessary
and will not significantly alter the course of this pandemic illness, or the
final death count.
Buy New $145.80 ($1.22 /
Fl Oz)(as
of 03:56 EDT - Details)
As reported by British
Sky News,51 October 7, 2020, many respected scientists are now
calling for a herd immunity approach to the pandemic, meaning governments
should allow people who are not at significant risk of serious COVID-19 illness
to go back to normal life. According to the article:52
“The so-called Great Barrington
declaration, signed by leading experts from the universities of Oxford,
Nottingham, Edinburgh, Exeter, Cambridge, Sussex and York, suggests herd
immunity as a way forward.
The declaration states: ‘The
most compassionate approach that balances the risks and benefits of reaching
herd immunity, is to allow those who are at minimal risk of death to live their
lives normally to build up immunity to coronavirus through natural infection,
while better protecting those who are at highest risk. We call this focused
protection.”
The declaration points out
that current lockdown policies are having “devastating effects on short and
long-term public health” that will result in excess mortality in the future,
primarily among younger people and the working class.
Sources and References
- 1 CDC.gov August 26, 2020
- 2 Annals of Internal Medicine September 2, 2020 DOI:
10.7326/M20-5352
- 3 Greek Reporter June 27, 2020
- 4 Washington Examiner July 2,
2020
- 5 FEE.org July 2, 2020
- 6, 9 Technical Report June 2020
DOI: 10.13140/RG.2.24350.77125
- 7, 8 YouTube, SARS-CoV-2 and the
rise of medical technocracy, Lee Merritt, MD, aprox 8 minutes in (Lie No.
1: Death Risk)
- 10 Cell June 25, 2020; 181(7):
1489-1501.E15
- 11 Wall
Street Journal June 12, 2020 (Archived)
- 12, 14 Nature Immunology September 30, 2020 DOI:
10.1038/s41590-020-00808-x
- 13 Immunology Virology June 17, 2020 DOI:
10.21203/rs.3.rs-35331/v1
- 15 The Lancet Microbe September
4, 2020 DOI: 10.1016/S2666-5247(20)30114-2
- 16, 17 UPI September 4, 2020
- 18, 22 Nature July 15, 2020; 584: 457-462
- 19 Daily Mail June 12, 2020
- 20 Science Times June 12, 2020
- 21 Biorxiv preprint DOI:
10.1101/2020.05.26.115832 (PDF)
- 23, 26, 27 Cell October 1, 2020; 183(1):
158-168.E14
- 24 BBC July 1, 2020
- 25 BioRxiv June 29, 2020 DOI:
10.1101/2020.06.29.174888
- 28 Khan Academy, Adaptive
Immunity
- 29 Cell May 14, 2020 DOI:
10.1016/j.cell.2020.05.015
- 30 Vaccine January 10, 2020;
38(2): 350-354
- 31 Unherd.com June 4, 2020
- 32 Metro August 24, 2020
- 33 The Sun August 24, 2020
- 34 The Guardian September 22,
2020
- 35, 36 The
Guardian September 16, 2020
- 37, 38 The New York Times April 23,
2020
- 39, 44 medRxiv May 21, 2020
DOI: 10.1101/2020.04.27.20081893 (PDF)
- 40, 41 Off-Guardian July 7,
2020
- 42, 47 medRxiv May 22, 2020 DOI:
10.1102/2020.05.19.20104596 (PDF)
- 43 Andrewbostom.org September
2020
- 45 medRxiv September 10, 2020
DOI: 10.1101/2020.09.06.20189290
- 46 medRxiv August 31, 2020 DOI:
10.1101/2020.07.23.20160762
- 48 Cornell University arXiv.org May 6, 2020
- 49 Science August 14, 2020;
369(6505): 846-849
- 50 Immunity May 19, 2020; 52(5):
737–741
- 51, 52 Sky News October 7, 2020
Copyright © Dr. Joseph
Mercola
https://www.lewrockwell.com/2020/10/joseph-mercola/majority-are-already-immune-against-sars-cov-2/